Skip to main content
SHIN NIPPON BIOMEDICAL LABORATORIES, LTD. logo

SHIN NIPPON BIOMEDICAL LABORATORIES, LTD. — Investor Relations & Filings

Ticker · 2395 ISIN · JP3379950003 LEI · 529900C10QR47J2U5R44 T Professional, scientific and technical activities
Filings indexed 68 across all filing types
Latest filing 2017-08-10 Interim / Quarterly Rep…
Country JP Japan
Listing T 2395

About SHIN NIPPON BIOMEDICAL LABORATORIES, LTD.

https://en.snbl.com/

Shin Nippon Biomedical Laboratories, Ltd. (SNBL) is a contract research organization (CRO) providing comprehensive drug development services. Established in 1957 as Japan's first CRO, the company supports pharmaceutical clients throughout the development lifecycle, from preclinical safety studies to clinical trial management. SNBL offers a full suite of services, including safety assessments and clinical data management. A key area of innovation is its proprietary nasal drug delivery technology, SMART (Simple MucoAdhesive Release Technology). The company's mission is to contribute to medical advancement and alleviate patient suffering by supporting the creation of new pharmaceuticals.

Recent filings

Filing Released Lang Actions
四半期報告書-第45期第1四半期(2017/04/01-2017/06/30)
Interim / Quarterly Report Classification · 100% confidence The document is a 'Quarterly Report' (四半期報告書) for Shin Nippon Biomedical Laboratories, Ltd. for the first quarter of the 45th fiscal year (April 1, 2017 to June 30, 2017). It contains detailed financial statements, including the balance sheet, income statement, and comprehensive income statement, as well as management's analysis of financial conditions and results of operations. This fits the definition of an Interim/Quarterly Report (IR). Q1 2018
2017-08-10 Japanese
有価証券報告書-第44期(2016/04/01-2017/03/31)
Annual Report Classification · 100% confidence The document is a Japanese 'Yuuka Shouken Houkokusho' (Securities Report), which is the Japanese equivalent of an Annual Report (10-K). It contains the official filing cover page, fiscal year information (44th term, ending March 31, 2017), and detailed financial tables (consolidated management indicators). It is a comprehensive annual financial disclosure document, not an announcement or a summary. FY 2017
2017-06-30 Japanese
四半期報告書-第44期第3四半期(2016/10/01-2016/12/31)
Interim / Quarterly Report Classification · 100% confidence The document is a 'Quarterly Report' (四半期報告書) for Shin Nippon Biomedical Laboratories, Ltd., covering the third quarter of the 44th fiscal period (April 1, 2016, to December 31, 2016). It contains detailed financial statements, including the balance sheet and income statement, and is filed under the Financial Instruments and Exchange Act. This fits the definition of an Interim/Quarterly Report (IR). 9M 2017
2017-02-14 Japanese
四半期報告書-第44期第2四半期(2016/07/01-2016/09/30)
Interim / Quarterly Report Classification · 100% confidence The document is a 'Quarterly Report' (四半期報告書) for Shin Nippon Biomedical Laboratories, Ltd. for the second quarter of the fiscal year 2016. It contains detailed financial statements, management analysis, and auditor review information, which fits the definition of an Interim/Quarterly Report (IR). It is not an announcement of a report, but the report itself. H1 2017
2016-11-14 Japanese
四半期報告書-第44期第1四半期(2016/04/01-2016/06/30)
Interim / Quarterly Report Classification · 100% confidence The document is a 'Quarterly Report' (四半期報告書) for Shin Nippon Biomedical Laboratories, Ltd. for the first quarter of the 44th fiscal year (April 1, 2016 to June 30, 2016). It contains detailed financial statements, including the balance sheet and income statement, and is filed in accordance with the Financial Instruments and Exchange Act. It is a comprehensive financial report for a period shorter than a full fiscal year, fitting the definition of an Interim/Quarterly Report (IR). Q1 2017
2016-08-12 Japanese
有価証券報告書-第43期(2015/04/01-2016/03/31)
Annual Report
2016-06-30 Japanese

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.